To explore the heterogeneity of T cell compartment and the characteristics of tumor-reactive T cells, we collected BM T cells from 5 newly diagnosed AML patients with RUNX1::RUNX1T1 and performed scRNA-seq and scV(D)J-seq (Fig. 1A). This evidence concerns the gene RUNX1 and neoplasm.